| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383767A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | CA2383743A1 Quorum sensing signaling in bacteria |
| 03/15/2001 | CA2383638A1 Monomeric analogues of human insulin |
| 03/15/2001 | CA2383563A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | CA2383321A1 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | CA2383186A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2379532A1 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | CA2376106A1 Paramyxoviruses comprising modified transcription start sequence |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/14/2001 | EP1083231A1 Smooth muscle cell promoter and uses thereof |
| 03/14/2001 | EP1083227A1 Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1082463A1 Mechanical stress induced genes, expression products therefrom, and uses thereof |
| 03/14/2001 | EP1082457A2 Nucleic acid encoding rate agouti related protein |
| 03/14/2001 | EP1082446A1 Recombinant aav vectors for gene therapy of hemophilia a |
| 03/14/2001 | EP1082445A2 Adeno-associated viral vector-mediated expression of factor viii activity |
| 03/14/2001 | EP1082444A1 Adeno-associated virus vectors and uses thereof |
| 03/14/2001 | EP1082437A1 Xenobiotic related induction of gene expression |
| 03/14/2001 | EP1082436A2 Moraxella catarrhalis pilq proteins |
| 03/14/2001 | EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/14/2001 | EP1082434A1 NOVEL INSECTICIDAL TOXINS FROM $i(XENORHABDUS NEMATOPHILUS) AND NUCLEIC ACID SEQUENCES CODING THEREFOR |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082431A2 Protease inhibitor peptides |
| 03/14/2001 | EP1082430A1 Kunitz domain polypeptide and materials and methods for making it |
| 03/14/2001 | EP1082429A2 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY |
| 03/14/2001 | EP1082428A2 Inhibition of viral infection and spread with viral and rhoa-derived peptides |
| 03/14/2001 | EP1082427A2 Insulin-like growth factor binding protein-3 variants |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082425A2 Ion channels |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082423A1 Cyclin e2 genes and proteins |
| 03/14/2001 | EP1082422A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation |
| 03/14/2001 | EP1082421A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 03/14/2001 | EP1082420A2 Human nucleic acid sequences from normal pancreas tissue |
| 03/14/2001 | EP1082417A1 Phenotype modifying genetic sequences |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082413A2 Aav5 vector and uses thereof |
| 03/14/2001 | EP1082409A1 RESISTANCE IN PLANTS TO INFECTION BY ssDNA VIRUS USING INOVIRIDAE VIRUS ssDNA-BINDING PROTEIN, COMPOSITIONS AND METHODS OF USE |
| 03/14/2001 | EP1082346A1 Specific binding proteins for treating canine allergy |
| 03/14/2001 | EP1082345A1 Method of designing agonists and antagonists to egf receptor family |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082342A2 Vaccine for pseudomonas aeruginosa |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082142A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/14/2001 | EP1082011A2 Avian polyomavirus vaccines in psittacine birds |
| 03/14/2001 | EP0960128A4 Gene product over expressed in cancer cells |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0804478B1 Growth factor analogs |
| 03/14/2001 | EP0675730B1 Therapeutic combination containing interferon |
| 03/14/2001 | EP0671472B1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 03/14/2001 | EP0640143B1 Senescent cell derived inhibitors of dna synthesis |
| 03/14/2001 | EP0569527B1 Inherited and somatic mutations of apc gene in colorectal cancer of humans |
| 03/14/2001 | CN1287574A Genes expressed in human monocytes and human macrophages |
| 03/14/2001 | CN1287492A Method for administering ASPB 28-human insulin |
| 03/14/2001 | CN1287491A Method for administering monomeric insulin analogs |
| 03/14/2001 | CN1287124A Recombined natural and new-type human insulin and its preparation |
| 03/14/2001 | CN1063185C Heri factor coupled material, its producing method, composition containing it and application thereof |
| 03/13/2001 | US6201168 Transgenic knockout mouse whose genome has homozygous disruption in endogenous beta-sarcoglycan gene; drug screening for treatments of muscular dystrophies and ischemic injuries; antiischemic agents |
| 03/13/2001 | US6201167 Producing transgenic mouse whose genome includes expression system of a promoter, a signal sequence and a dna sequence encoding the desired protein; then collecting semen |
| 03/13/2001 | US6201166 Transgenic mouse hepatitis C virus model comprising a hepatitis C viral fragment |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201114 Identification of congenital stationary night blindness in dogs |
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201107 Cystic fibrosis gene |
| 03/13/2001 | US6201106 Cytokine signal regulators |
| 03/13/2001 | US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis |
| 03/13/2001 | US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6200955 Heparin binding peptides |
| 03/13/2001 | US6200954 Small peptides having potent anti-angiogenic activity |
| 03/13/2001 | US6200953 Relaxin analogs and derivatives compositions |
| 03/13/2001 | US6200811 For making human immunodeficiency virus resistant cells; gene therapy |
| 03/13/2001 | US6200810 Administering a synthetic mutated retinoblastoma gene encoding a protein resistant to deactivation by phosphorylation; antiproliferative/anticancer agents |
| 03/13/2001 | US6200803 Preventing fungal contamination in cell culture by incubating cells in cell culture medium with either antisense oligonucleotide or ribozyme complementary to messenger rna of essential yeast genes |
| 03/13/2001 | US6200802 Human peroxisome proliferator activated receptor gamma: compositions and methods |
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200799 Replication-defective recombinant virus includes promoter from human major intrinsic protein or human crystallin and an open reading frame of human ras, herpes simplex type i thymidine kinase, or non-phosphorylatable retinoblastoma |
| 03/13/2001 | US6200798 Defective recombinant adenoviruses with inactivated IVa2 gene |
| 03/13/2001 | US6200790 Vesicle transport associated proteins |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200785 L-lysine-producing corynebacteria and process for the preparation of l-lysine |
| 03/13/2001 | US6200782 Fusion proteins linked to nucleotide sequences; for the preferential adjustment of nucleotide sequences |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200778 Genomic sequences for protein production and delivery |
| 03/13/2001 | US6200777 Human p101 polynucleotides |